Default company panoramic image

CritiTech, Inc.

CritiTech is a pharmaceutical-sciences firm owning patented technologies that improve the efficacy of medical products and processes.

  • Stage $1M in TTM Revenue
  • Industry Nanotechnology
  • Location Lawrence, KS, USA
  • Currency USD
  • Founded January 1997
  • Employees 11
  • Website

Company Summary

The Company’s business lines include drug product development, Lyophobic Precipitation (a drying technology) and medical device and drug product coating. The keystone platform is its innovative and proprietary method of utilizing supercritical fluid technology, which allows reproducible manufacture of sub-micron particles. This process solves many problems associated with other size-reduction processes for drug manufacturers and distributors.


  • Default avatar
    Sam Campbell
    President & Chairman

    Mr. Campbell has over 25 years of experience managing early-stage life science and technology companies and has overseen the construction of a sophisticated bio/chem wet lab that currently houses others. He has also procured start-up capital and provided management support for numerous successful life science companies. He received his undergraduate and M.B.A. degrees from the University of Kansas.

  • Default avatar
    David Johnston

    Dr. Johnston is a senior pharmaceutical executive with extensive experience in pre-clinical and clinical drug development, regulatory affairs and product commercialization, pegylation technology and quality control / assurance for clinical supplies. He has bachelor’s and doctorate degrees in chemistry from St. Andrews University (Scotland) and completed post-doctoral training at the Max Planck Institute for Medicinal research (Germany).


  • Default avatar
    James Long, Lawrence, Kansas; Consultants: Dr. Joseph Fix, 25+ years in drug delivery and nanoparticle pharmaceuticals industries; Dr. William P. Duncan, former President of the Kansas City Area Life Sciences Institute

Previous Investors

  • Default avatar
    Kansas Technology Enterprise Corp., Midwest Venture Alliance and other individual investors.
    Default avatar
    ($2MM of current $5MM round already committed).